CGP-39551
Overview[edit]
CGP-39551 is a chemical compound that acts as a competitive antagonist of the NMDA receptor. It is primarily used in research settings to study the role of NMDA receptors in various physiological and pathological processes.
Chemical Structure[edit]
CGP-39551 is chemically known as (E)-(4-Amino-5-ethoxy-2-methyl-5-oxopent-2-en-1-yl)phosphonic acid. The structure of CGP-39551 includes a phosphonic acid group, which is crucial for its activity as an NMDA receptor antagonist.
Mechanism of Action[edit]
CGP-39551 functions by binding to the glutamate site on the NMDA receptor, thereby inhibiting the action of glutamate, which is the primary excitatory neurotransmitter in the central nervous system. This inhibition can help in reducing excitotoxicity, which is implicated in various neurological disorders.
Applications in Research[edit]
CGP-39551 is used extensively in neuroscience research to explore the role of NMDA receptors in synaptic plasticity, learning, and memory. It is also used to investigate the potential therapeutic effects of NMDA receptor antagonists in conditions such as epilepsy, ischemic stroke, and neurodegenerative diseases.
Pharmacological Properties[edit]
As a competitive antagonist, CGP-39551 competes with glutamate for binding to the NMDA receptor. This property makes it a valuable tool for dissecting the contributions of NMDA receptor-mediated signaling in various physiological and pathological contexts.
Safety and Toxicity[edit]
In research settings, the safety and toxicity of CGP-39551 are important considerations. While it is a potent antagonist, its effects are dose-dependent, and care must be taken to avoid potential neurotoxic effects associated with excessive NMDA receptor inhibition.
-(4-Amino-5-ethoxy-2-methyl-5-oxopent-2-en-1-yl)phosphonic_acid.png){kind=link}